With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Yet another large analysis, this one a meta-analysis of systemic therapy trials for women with advanced ovarian cancer, indicates progression-free survival means little to nothing if not followed-on by confirmatory overall-survival measures. | Paoletti, JAMA Netw Open 2020